JDE Peet’s to hold Extraordinary General Meeting of Shareholders on 18 November 2020
Amsterdam, 2 October 2020
JDE Peet’s (EURONEXT: JDEP), the world's largest pure-play coffee and tea group by revenue, today convened an Extraordinary General Meeting of Shareholders (EGM) to be held on 18 November 2020 at 1:00PM CET.
In accordance with the Temporary COVID-19 Justice and Safety Act, the Board of Directors (the Board) has decided that shareholders can can only attend the meeting virtually on the internet at www.abnamro.com/evoting. The meeting can also be followed on JDE Peet’s’ website.
During this virtual EGM, the following resolution items will addressed:
- Proposal to appoint Mr. Fabien Simon as executive member of the Board
- Proposal to make a technical amendment to JDE Peet’s’ Directors’ Remuneration Policy
- Proposal to appoint Mr. Frank Engelen as non-executive member of the Board
The agenda with the explanatory notes and other information relevant to the EGM are available on JDE Peet’s’ website.
Mr. Fabien Simon (1971) is French and currently a non-executive Director of JDE Peet’s. He also serves as chairman of JAB’s pet care platform. Previously, he was a Partner and the CFO of JAB and was responsible for leading the successful IPO on the Euronext Amsterdam stock exchange in May 2020. Between August 2014 and January 2019, he was the CFO of Jacobs Douwe Egberts B.V., during which time he led its M&A strategy and multiple large-scale integrations. Prior to JDE, he spent 13 years at Mars Inc., holding various finance leadership roles, including Asia Pacific CFO, Vice President and CFO Petcare Europe and Finance Director Europe. Fabien also spent eight years at Valeo in a variety of leadership roles, including Finance Director. He holds a Master's degree in Finance and Economics from the University of Picardie Jules Verne, Amiens and a Chartered Accountant Certificate. He lives in Amsterdam with his wife and three children.
Mr. Frank Engelen (1971) is Dutch and has been a partner of JAB since September 2020. Before becoming a JAB partner, he was a partner of PwC for 17 years, during which time he was a member of the Board of PwC Netherlands for five years, and a member of the Board of PwC Europe for two years. Mr. Frank Engelen holds a Master’s degree in tax law and a PhD from the University of Rotterdam.
Investors & Analysts
+31 6 1594 4569
Global Communications Director
About JDE Peet’s
JDE Peet’s is the world's largest pure-play coffee and tea group by revenue, serving approximately 130 billion cups of coffee and tea in the financial year ended 31 December 2019 (“FY”) in more than 100 developed and emerging countries. With a portfolio of more than 50 leading global, regional and local coffee and tea brands, JDE Peet’s offers an extensive range of high-quality and innovative coffee and tea products and solutions to serve consumer needs across markets, consumer preferences and price levels. In FY 2019, JDE Peet’s generated total sales of EUR 6.9 billion and had on average 21,255 employees worldwide. The JDE Peet’s global portfolio includes: Jacobs, Peet’s, L’OR, Senseo, Tassimo and Ti Ora. For more information please visit JDE Peet’s website.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
RESULT OF RIKSBANK CERTIFICATE SALE1.12.2020 10:15:00 CET | Press release
RESULT OF RIKSBANK CERTIFICATE SALE CERTIFICATE MATURITY201209 FIXED RATE0.00 %OFFERED VOLUME380.000 BLNTOTAL BID AMOUNT1 526.300 BLNACCEPTED VOLUME 380.000 BLN PERCENTAGE ALLOTTED 24.8970 %NUMBER OF BIDS15DEPOSIT RATE-0.10 %LENDING RATE0.10 %
Net asset value as per November 30, 20201.12.2020 10:00:00 CET | Press release
On November 30, 2020, net asset value was SEK 278 per share. The closing price on November 30, 2020, was SEK 265.00 for the Class A shares and SEK 261.60 for the Class C shares. Stockholm, December 1, 2020 AB INDUSTRIVÄRDEN (publ) For further information, please contact: Sverker Sivall, Head of Corporate Communication and Sustainability, tel. +46-8-666 64 00 Submitted for publication on December 1, 2020 at 10:00 a.m. Attachment Substansvarde_201201_eng
Substansvärdet per den 30 november 20201.12.2020 10:00:00 CET | Pressemelding
Den 30 november 2020 var substansvärdet 278 kronor per aktie. Sista stängningskurs den 30 november 2020 var 265,00 kronor för A-aktien och 261,60 kronor för C-aktien. Stockholm den 1 december 2020 AB INDUSTRIVÄRDEN (publ) För ytterligare information kontakta: Sverker Sivall, Kommunikations- och hållbarhetschef, telefon 08-666 64 00 Lämnad för publicering den 1 december 2020, kl. 10:00. Bilaga Substansvarde_201201_sve
Exercise of warrants in Better Collective A/S; Board of Directors issues 111,086 new ordinary shares1.12.2020 08:45:00 CET | Press release
Regulatory Release 44/2020 In the exercise window which opened on November 11, 2020 following Better Collective’s Q3 report and closed on November 26, 2020, 22 employees have informed the company that they wish to exercise in total 111,086 warrants under the 2017 warrant program. The 2017 warrant program was established prior to the company’s IPO and the warrants were issued in 2017 and 2018. Reference is made to schedule 2 of the company’s articles of association for detailed terms of conditions of the warrants. As of November 11, 2020, 715,708 warrants remain outstanding (excluding the warrants exercised following the Q3 report) under the 2017 warrant program, all with rights to subscribe for 1 ordinary share in Better Collective A/S against payment of an exercise price of DKK 12.962962 per warrant. Today Better Collective’s board of directors resolved to carry out the capital increase related to the exercise of warrants. The new shares will be issued through VP Securities under the
Participation Notification by Blackrock Inc.1.12.2020 08:30:00 CET | Press release
Brussels, December 1, 2020, 08:30 CET - According to Belgian transparency legislation (Law of May 2, 2007), BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.) recently sent to Solvay the following transparency notification indicating that it crossed the threshold of 3%. Here is a summary of the move: Date on which the threshold was crossedVoting rights after the transactionEquivalent financial instruments after the transactionTotalNovember 25, 20202.61%0.39%3.00% The latest notification, dated November 26, 2020, contains the following information: Reason for the notification: acquisition or disposal of voting securities or voting rightsNotified by: BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.)Date on which the threshold is crossed: November 25, 2020Threshold of direct voting rights crossed: 3% upwardsDenominator: 105,876,416Additional information: The disclosure obligation arose due to voting rights attached to shares for BlackRock, Inc. going above 3
Arcoma lanserar nya röntgensystemet OMNERA 500A på amerikanska marknaden1.12.2020 08:30:00 CET | Pressemelding
2020-12-01 PRESSRELEASE Arcoma lanserar nya röntgensystemet OMNERA 500A på amerikanska marknaden Arcoma AB lanserar idag det nya röntgensystemet OMNERA 500A på den amerikanska marknaden. OMNERA 500A erbjuder nya intelligenta automatiseringsfunktioner för att förbättra arbetsflödet och effektiviteten men även patientvården. OMNERA 500A erbjuder enastående prestanda och intelligent automatisering med funktioner som sätter effektivitet och patientsäkerhet främst. Systemet har ny design och ett nytt modernt användargränsnitt med smarta funktioner som förenklar arbetsflödet och är utformat för att underlätta desinficering. OMNERA 500A har också ett helt nytt väggstativ och ett uppdaterat röntgenbord som förbättrar patient- och användarupplevelsen. OMNERA 500A lanseras genom Arcomas partner Canon Medical Systems USA på den årliga mässan RSNA som i år utförs digitalt. Mässan pågår hela denna vecka. För att se det nya systemet i Canon Medical Systems digitala monter, besök deras hemsida: https